Evaluation of Adherence Should Become an Integral Part of Assessment of Patients With Apparently Treatment-Resistant Hypertension.

Berra , Elena; Azizi, Michel; Capron, Arnaud; Høieggen, Aud; Rabbia, Franco; Kjeldsen, Sverre E; Staessen, Jan A; Wallemacq, Pierre; Persu, Alexandre

doi:10.1161/HYPERTENSIONAHA.116.07464

Evaluation of Adherence Should Become an Integral Part of Assessment of Patients With Apparently Treatment-Resistant Hypertension.

Berra , Elena

;

Azizi, Michel

;

Capron, Arnaud

;

Høieggen, Aud

;

Persu, Alexandre

;et.al.

(2016) Hypertension — Vol. 68, n° 2, p. 297-306 (2016)

Files

2016_Berra_Hypertension.pdf

Restricted Access
Adobe PDF
1.05 MB

Request a copy

Details

Authors

Berra , ElenaUCLouvain
Author
Azizi, Michel
Author
Capron, ArnaudUCLouvain
Author
Høieggen, Aud
Author
Wallemacq, PierreUCLouvain
Author
Persu, AlexandreUCLouvain
Author

Affiliations

UCLouvainSSS/IREC/CARD - Pôle de recherche cardiovasculaire
UCLouvainSSS/IREC/LTAP - Louvain Centre for Toxicology and Applied Pharmacology
UCLouvain(SLuc) Service de cardiologie
UCLouvain(SLuc) Service de biochimie médicale

Citations

APA
Chicago
FWB

Berra, E., Azizi, M., Capron, A., Høieggen, A., Rabbia, F., Kjeldsen, S. E., Staessen, J. A., Wallemacq, P., & Persu, A. (2016). Evaluation of Adherence Should Become an Integral Part of Assessment of Patients With Apparently Treatment-Resistant Hypertension. Hypertension, 68(2), 297-306. https://doi.org/10.1161/HYPERTENSIONAHA.116.07464 (Original work published 2016)